Identification and in vitro characterization of novel nanobodies against human granulocyte colony-stimulating factor receptor to provide inhibition of G-CSF function.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biopha.2017.06.025PMID 28646705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Production of Novel VHH Nanobody Inhibiting Angiogenesis by Targeting Binding Site of VEGF

  2015cited by this paper
• Production of Nanobodies against Prostate-Specific Membrane Antigen (PSMA) Recognizing LnCaP Cells

  2014cited by this paper
• A general protocol for the generation of Nanobodies for structural biology

  2014cited by this paper
• Selection and characterization of llama single domain antibodies against N-terminal huntingtin

  2014cited by this paper
• Targeting tumors with nanobodies for cancer imaging and therapy.

  2013cited by this paper
• Development of Oligoclonal Nanobodies for Targeting the Tumor-Associated Glycoprotein 72 Antigen

  2013cited by this paper
• A novel VHH nanobody against the active site (the CA domain) of tumor-associated, carbonic anhydrase isoform IX and its usefulness for cancer diagnosis

  2013cited by this paper
• Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor.

  2012cited by this paper
• Llama Antibody Fragments Recognizing Various Epitopes of the CD4bs Neutralize a Broad Range of HIV-1 Subtypes A, B and C

  2012cited by this paper
• From whole monoclonal antibodies to single domain antibodies: think small.

  2012cited by this paper
• Nanobodies - from llamas to therapeutic proteins.

  2010cited by this paper
• Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

  2010cited by this paper
• Inaugural Article: Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes

  2010cited by this paper
• Amine coupling through EDC/NHS: a practical approach.

  2010cited by this paper
• G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis

  2009cited by this paper
• Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells.

  2009cited by this paper
• G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

  2009cited by this paper
• Hepatocellular carcinoma producing a granulocyte colony‐stimulating factor: report of a resected case with a literature review

  2007cited by this paper
• Properties, production, and applications of camelid single-domain antibody fragments

  2007cited by this paper
• Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development.

  2007cited by this paper
• Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease.

  2006cited by this paper
• Autocrine Growth of Transitional Cell Carcinoma of the Bladder Induced by Granulocyte-Colony Stimulating Factor 1

  2006cited by this paper
• Expression of granulocyte colony stimulating factor receptor in human colorectal cancer

  2005cited by this paper
• Identification of CCR2, flotillin, and gp49B genes as new G‐CSF targets during neutrophilic differentiation

  2005cited by this paper
• Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia.

  2005cited by this paper
• Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents.

  2004cited by this paper
• Granulocyte colony-stimulating factor (G-CSF) production by astrocytoma cells and its effect on tumor growth

  2004cited by this paper
• Single‐domain antibody fragments with high conformational stability

  2002cited by this paper
• Single domain camel antibodies: current status.

  2001cited by this paper
• Tumor‐related leukocytosis is linked with poor prognosis in patients with lung carcinoma

  2001cited by this paper
• Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

  2001cited by this paper
• G-CSF receptor expression in ovarian cancer.

  2000cited by this paper
• Granulocyte colony-stimulating factor: its potential role in infectious disease.

  1999cited by this paper
• Constitutive expression of G‐CSF and GM‐CSF in human skin carcinoma cells with functional consequence for tumor progression

  1999cited by this paper
• Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder.

  1998cited by this paper
• Granulocyte Colony-Stimulating Factor (G-CSF) and G-CSF Receptor on Neutrophils in Cancer Patients

  1998cited by this paper
• Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma.

  1998cited by this paper
• Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy

  1997cited by this paper
• Molecular analysis of the granulocyte colony-stimulating factor receptor.

  1996cited by this paper
• Establishment and characteristics of a gastric cancer cell line (HuGC‐OOHIRA) producing high levels of G‐CSF, GM‐CSF, and IL‐6: The presence of autocrine growth control by G‐CSF

  1995cited by this paper
• Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor.

  1995cited by this paper
• Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.

  1994cited by this paper
• Granulocyte colony-stimulating factor produced by bladder carcinoma of a patient with leukemoid reaction did not affect proliferation of the tumor cells.

  1994cited by this paper
• Naturally occurring antibodies devoid of light chains

  1993cited by this paper
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation.

  1992cited by this paper
• Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.

  1990cited by this paper
• Expression cloning of a receptor for murine granulocyte colony-stimulating factor.

  1990cited by this paper
• Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro.

  1989cited by this paper
• Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

  1989cited by this paper
• Various Human Hematopoietic Growth Factors (Interleukin-3, GM-CSF, G-CSF) Stimulate Clonal Growth of Nonhematopoietic Tumor Cells

  1989cited by this paper
• Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.

  1988cited by this paper
• Hemopoietic growth factors and their interactions with specific receptors

  1987cited by this paper
• Production of granulocyte colony-stimulating factor by a human melanoma cell line.

  1987cited by this paper
• Intraclonal diversity of fibrosarcoma cells for the production of macrophage colony‐stimulating factor and granulocyte colony‐stimulating factor

  1987cited by this paper
• Molecular cloning and characterization of a cDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21.

  1987cited by this paper
• Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor

  1986cited by this paper
• Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

  1985cited by this paper
• Constitutive production of leukemia differentiation, colony-stimulating, erythroid burst-promoting, and pluripoietic factors by a human hepatoma cell line: characterization of the leukemia differentiation factor.

  1985cited by this paper

• Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy

  2024cites this paper
• Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review).

  2023cites this paper
• SINGLE-DOMAIN ANTIBODIES APPLIED AS ANTIVIRAL IMMUNOTHERAPEUTICS.

  2023cites this paper
• In Silico Optimization of SARS-CoV-2 Spike Specific Nanobodies.

  2023cites this paper
• Angiogenic biomolecules specific nanobodies application in cancer imaging and therapy; review and updates.

  2022cites this paper
• Emerging applications of nanobodies in cancer therapy.

  2022cites this paper
• Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: A systematic review

  2022cites this paper
• Neuroprotection through G-CSF: recent advances and future viewpoints

  2021cites this paper
• Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics

  2020cites this paper
• Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function

  2020cites this paper
• Exploring cellular biochemistry with nanobodies

  2020cites this paper
• Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity.

  2020cites this paper
• Isolation and characterization of a novel nanobody for detection of GRP78 expressing cancer cells

  2020cites this paper
• Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer

  2019cites this paper
• Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy.

  2018cites this paper